Sophia Genetics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$19,462
$18,323
$17,779
$17,733
Gross Profit
12,907
12,270
12,208
12,102
EBITDA
-17,243
-18,723
-13,926
-7,946
EBIT
-18,338
-21,093
-16,223
-10,233
Net Income
-20,021
-22,414
-17,385
-15,158
Net Change In Cash
19,462
18,323
17,779
17,733
Free Cash Flow
-8,899
-10,190
-12,241
-12,541
Cash
81,610
94,822
68,528
80,226
Basic Shares
67,787
67,321
66,844
65,904

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$65,173
$62,371
$47,560
$40,450
Gross Profit
43,937
42,913
31,254
25,221
EBITDA
-50,761
-69,571
-81,375
-69,240
EBIT
-59,357
-77,907
-86,946
-72,849
Net Income
-62,493
-78,981
-87,449
-73,675
Net Change In Cash
65,173
62,371
47,560
40,450
Free Cash Flow
-50,998
-57,801
-80,474
-64,610
Cash
80,226
123,251
161,305
192,962
Basic Shares
65,782
64,750
64,099
55,299

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.30
2025-06-30
-$0.24
2025-03-31
-$0.26